PLANTS, THEIR PROPERTIES, YOUR BALANCE.
Botanical collection image: Psiloxylon mauritianum (Psiloxylon mauritianum (Bouton ex Hook.f.) Baill.)

BOTANICAL COLLECTION · MYRTACEAE

THE HERBARIUM · MYRTACEAE

Psiloxylon mauritianum

Psiloxylon mauritianum (Bouton ex Hook.f.) Baill.

Source topics

These topics describe what the sources discuss, including unproven claims and risks. They are not therapeutic recommendations.

Documentary entry
  • Listed part — documentary contextInsufficient evidence
  • Aspidins and antibacterial activityPreclinical research
Plant partleaf
FormsNo recommended preparation

Documentary entryReported uses only. No preparation or therapeutic use is recommended.

A research preparation is not equivalent to home use; the study’s limitations are stated.

Identity & origin

BOTANICAL IDENTITY

The right name is the first step.

A tree associated primarily with wet tropical environments. Kew now places this species in Myrtaceae; the French inventory uses the older family Psiloxylaceae. The leaf is the relevant material.

Part used
leaf
Origin & distribution
Mascarenes.

Also known as: No synonyms listed.

Have the species and exact part verified; a photograph alone cannot guarantee identification for consumption.

An illustration is not enough to identify a plant for consumption. Do not forage for a species based solely on this profile.

Uses & evidence

UNDERSTANDING THE USES

Properties & uses.

Insufficient evidence

Listed part — documentary context

ANSM lists Psiloxylon mauritianum for: leaf. This listing specifies neither a clinical indication nor a dosage.

The references do not establish a benefit. Lack of evidence is not assurance of safety.

Read the source
Preclinical research

Aspidins and antibacterial activity

Substances obtained from a leaf extract. Aspidin VB inhibited Staphylococcus aureus strains, including methicillin-resistant strains. No clinical trial; the finding does not justify replacing antibiotics or applying a preparation to an infection.

Laboratory or animal observation. A human benefit cannot be inferred from this finding alone.

Read the source

The traditional uses described are not clinical proof of effectiveness. Evidence for one preparation cannot automatically be applied to another.

Precautions before use

BEFORE ANY USE

Precautions & contraindications.

This guidance does not cover every individual situation. Missing information is not a guarantee of safety.

Contraindications & precautions

  • Insufficient dataThis targeted audit does not provide a comprehensive contraindication review; this does not mean contraindications are absent.

Medicine interactions

  • Insufficient dataThis dossier cannot establish compatibility with medication. A limited study does not replace an interaction review of the exact product.
Other retained warnings · review incomplete

These existing warnings remain relevant to consult. Their exhaustive reassessment is outside this targeted review.

Restrictions and precautions

  • The botanical sources cited cannot establish a complete list of contraindications. Do not self-medicate on the basis of this record.

Medicine interactions

  • Compatibility with medicines is not established by the sources evaluated here; ask a pharmacist to check the exact product.

Pregnancy, breastfeeding and children

Insufficient information here to recommend medicinal use during pregnancy or breastfeeding.

No preparation or paediatric dose is validated in this record.

“Reported” does not prove causality; “possible” may reflect indirect evidence. “None reported” means none in the cited source, not that all combinations have been studied. Do not stop a prescribed treatment based on this profile.

Adverse effects

  • The botanical inventory does not characterize adverse effects; this does not mean there is no risk.

Pregnancy & breastfeeding

Insufficient information here to recommend medicinal use during pregnancy or breastfeeding.

Children & adolescents

No preparation or paediatric dose is validated in this record.

If symptoms persist, worsen or are unusual, consult a healthcare professional. In an emergency, contact the emergency services.

Available evidence

EXPLORE THE EVIDENCE

The available evidence.

This research searches for candidate molecules. An isolated molecule and a whole leaf have different profiles; lack of toxicity in one cellular test does not establish human safety.

Constituents to know.

Their presence and quantity depend on the plant part and preparation.

Aspidins VB and BB
Substances isolated from leaves; their concentrations are not inferred for an herbal tea.Read the reference
Preclinical research

Aspidins and antibacterial activity

Laboratory bacterial inhibition does not establish that the leaf achieves the same exposure in a human body.

Laboratory or animal observation. A human benefit cannot be inferred from this finding alone.

Read the reference

Limitations to keep in mind.

This record explains a publication without turning it into a prescription. The studied part, process and context must remain identifiable.

Studies, findings & limitations

THE RESEARCH

What the research shows.

A laboratory or animal result alone does not demonstrate a benefit in humans. Each result must be read alongside the preparation studied and its limitations.

01Preclinical research

Aspidins and antibacterial activity

Laboratory or animal observation. A human benefit cannot be inferred from this finding alone.

Type of research
Chemical isolation and in-vitro microbiological tests.
Preparation concerned
Substances obtained from a leaf extract.
Observed results
Aspidin VB inhibited Staphylococcus aureus strains, including methicillin-resistant strains.
Limitations to consider
No clinical trial; the finding does not justify replacing antibiotics or applying a preparation to an infection.
Read the reference

Documentary review dated 09/10/2026. The references remain available to check the context.

Sources & last review
Looking for personal guidance?View consultations · from $40 USD
WhatsApp Appointments